 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Ira S. Nash | |
|---|---|
| Education | Harvard University Harvard University Medical School |
| Medical career | |
| Profession | cardiologist |
| Institutions | Mount Sinai Medical Center |
| Sub-specialties | heart disease |
Ira S. Nash is an American cardiologist. [1]
Nash is the senior vice president for physician leadership development at Northwell Health, and the associate dean for physician leadership development at the Zucker School of Medicine. [2]
Previously, Nash served as the Chief Medical Officer and Senior Vice President for Medical Affairs at the Mount Sinai Medical Center and Associate Professor of both Medicine and Health Evidence and Policy at the Mount Sinai School of Medicine. [3]
Nash serves and has served on various editorial boards including Cardiovascular Review and Reports, the American Journal of Medical Quality, [4] the American Journal of Medicine and the Mount Sinai Journal of Medicine. He has published more than 30 articles and 13 books and book chapters and is an associate editor of Hurst's The Heart , a leading textbook. [5] From 1998-2000 he was the host of WCBS-TV's “2 Your Health”. He is the host of the Well Said podcast. [6]
Nash is a member of the Clinical Council of the American Heart Association (AHA) and serves on the American College of Cardiology (ACC)/AHA Joint Task Force on Clinical Competence, [7] which sets standards for training and expertise in cardiovascular medicine.
Nash was named in Castle Connolly's list of “Best Doctors” in 2007, 2008, 2010 and 2011 [8] and in the New York Times list of "Super Doctors" in 2008, 2009 and 2010. [9]
Nash received his A.B., summa cum laude, in Engineering and Applied Science in 1980 from Harvard University and his M.D., cum laude, in 1984 from Harvard Medical School. [10] His internship (1984–1985) and his residency (1985–1987) in medicine were both at The Beth Israel Hospital in Boston, Massachusetts. From 1987-1989 he was a clinical fellow in Medicine (Cardiology) at Harvard Medical School and Beth Israel Hospital.
Nash served on the full-time academic staff of the Cardiac Unit of the Massachusetts General Hospital and on the faculty of Harvard Medical School until 1995, when he joined the Mount Sinai Medical Center. [11]
Nash is a Fellow of the American College of Cardiology, the American Heart Association and the American College of Physicians. [2]
As of 2011, Nash was Commander in the Medical Corps of the United States Navy Reserve. [12]
As of 2020, he was the Executive Director of Northern Health Physician Partners. [13]
Partial list:[ citation needed ]
Werner Theodor Otto Forßmann was a German researcher and physician from Germany who shared the 1956 Nobel Prize in Medicine for developing a procedure that allowed cardiac catheterization. In 1929, he put himself under local anesthesia and inserted a catheter into a vein of his arm. Not knowing if the catheter might pierce a vein, he put his life at risk. Forssmann was nevertheless successful; he safely passed the catheter into his heart.
Atrial septal defect (ASD) is a congenital heart defect in which blood flows between the atria of the heart. Some flow is a normal condition both pre-birth and immediately post-birth via the foramen ovale; however, when this does not naturally close after birth it is referred to as a patent (open) foramen ovale (PFO). It is common in patients with a congenital atrial septal aneurysm (ASA).
Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter.
Mitral regurgitation(MR), also known as mitral insufficiency or mitral incompetence, is a form of valvular heart disease in which the mitral valve is insufficient and does not close properly when the heart pumps out blood. It is the abnormal leaking of blood backwards – regurgitation from the left ventricle, through the mitral valve, into the left atrium, when the left ventricle contracts. Mitral regurgitation is the most common form of valvular heart disease.
Eisenmenger syndrome or Eisenmenger's syndrome is defined as the process in which a long-standing left-to-right cardiac shunt caused by a congenital heart defect causes pulmonary hypertension and eventual reversal of the shunt into a cyanotic right-to-left shunt. Because of the advent of fetal screening with echocardiography early in life, the incidence of heart defects progressing to Eisenmenger syndrome has decreased.
The Icahn School of Medicine at Mount Sinai, formerly the Mount Sinai School of Medicine, is a private medical school in New York City, New York, United States. The school is the academic teaching arm of the Mount Sinai Health System, which manages eight hospital campuses in the New York metropolitan area, including Mount Sinai Hospital and the New York Eye and Ear Infirmary.
Accelerated idioventricular rhythm is a ventricular rhythm with a rate of between 40 and 120 beats per minute. Idioventricular means “relating to or affecting the cardiac ventricle alone” and refers to any ectopic ventricular arrhythmia. Accelerated idioventricular arrhythmias are distinguished from ventricular rhythms with rates less than 40 and those faster than 120. Though some other references limit to between 60 and 100 beats per minute. It is also referred to as AIVR and "slow ventricular tachycardia."
Valentín Fuster Carulla, 1st Marquess of Fuster is a Spanish cardiologist and aristocrat.
David H. Adams is an American cardiac surgeon and the Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai Hospital in New York City. Dr. Adams is a recognized leader in the field of heart valve surgery and mitral valve reconstruction. As director of Mount Sinai Mitral Valve Repair Center, he has set national benchmarks with >99% degenerative mitral valve repair rates, while running one of the largest valve repair programs in the United States. Dr. Adams is the co-inventor of 2 mitral valve annuloplasty repair rings – the Carpentier-McCarthy-Adams IMR ETlogix Ring and the Carpentier-Edwards Physio II Annuloplasty Ring, and is a senior consultant with royalty agreements with Edwards Lifesciences. He is also the inventor of the Tri-Ad Adams Tricuspid Annuloplasty ring with a royalty agreement with Medtronic. He is a co-author with Professor Alain Carpentier of the benchmark textbook in mitral valve surgery Carpentier's Reconstructive Valve Surgery. He is also the National Co-Principal Investigator of the FDA pivotal trial of the Medtronic-CoreValve transcatheter aortic valve replacement device.
Sean Patrick Pinney is an American cardiologist and the Director of both the Advanced Heart Failure and Cardiac Transplant Program and the Pulmonary Hypertension Program at Mount Sinai Medical Center in New York City.
Mary Ann McLaughlin is an American cardiologist, the author of multiple book chapters and an associate professor at Mount Sinai Medical Center in New York City.
Annapoorna Kini is an American cardiologist. She is Professor of Cardiology and Interventional Director of Structural Heart Program at Mount Sinai School of Medicine in New York City.
Jonathan L. Halperin is an American cardiologist and the author of Bypass (ISBN 0-89586-509-2), among the most comprehensive works on the subject of coronary artery bypass surgery. In addition, he is the Robert and Harriet Heilbrunn Professor of Medicine at The Mount Sinai School of Medicine as well as Director of Clinical Cardiology in the Zena and Michael A. Wierner Cardiovascular Institute at The Mount Sinai Medical Center, both in New York City. Halperin was the principal cardiologist responsible for both the design and execution of the multi-center Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, funded by the National Institutes of Health, which helped develop antithrombotic strategies to prevent stroke, and he subsequently directed the SPORTIF clinical trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation.
Barry A. Love is an American cardiologist specializing in pediatric and congenital heart problems.
Peter R. Kowey is an American cardiologist and medical researcher. He is Professor of Medicine and Clinical Pharmacology at Jefferson Medical College of Thomas Jefferson University and holds the William Wikoff Smith Chair in Cardiovascular Research at Lankenau Institute for Medical Research.
Dr Anil Pareek; is an Indian medical researcher with contributions in hypertension, metabolic disorder and inflammation. His prior experience includes academics and clinical practice. He is involved in drug development process targeting therapy gaps to create scope for innovative products.
Thomas G. Pickering was a British physician and academic. He was a professor of medicine at College of Physicians and Surgeons, Columbia University Medical Center in New York City. He was an internationally renowned expert in clinical hypertension and a leader in the fields of hypertension and cardiovascular behavioral medicine. He coined the term "white-coat hypertension" to describe those whose blood pressure was elevated in the doctor's office, but normal in everyday life. He later published the first editorial describing "masked hypertension". He also discovered and gave his name to the Pickering Syndrome, where bilateral renal artery stenosis causes flash pulmonary edema.
Dr. Robert S. Rosenson is a Professor of Medicine and also lending his services as the Director of cardio metabolic disorders at the Icahn School of Medicine at Mount Sinai.
Samin K. Sharma is an American philanthropist of Indian descent and an interventional cardiologist who co-founded the Eternal Heart Care Centre and Research Institute in Jaipur (EHCC). Sharma has served on New York State’s Cardiac Advisory Board since 2004. As of 2021, he is Senior Vice-President, Operations & Quality at The Mount Sinai Hospital in New York and runs the Dr. Samin K. Sharma Family Foundation Cardiac Catheterization Laboratory. As of 2018, he is Chairman Board of Trustees, Association of Indians in America (AIA). As of 2022, he has been an investigator on 86 grants and multi-center trials and authored 486 peer-reviewed articles that have been cited 21,734 times.
Roxana Mehran is an Iranian-American cardiologist and Mount Sinai Endowed Professor of Medicine at the Icahn School of Medicine at Mount Sinai. She is known for her work in interventional cardiology.
